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Summary
Burkholderia mallei is a facultative intracellular patho-
gen that can cause fatal disease in animals and
humans. To better understand the role of phagocytic
cells in the control of infections caused by this organ-
ism, studies were initiated to examine the interactions
of B. mallei with RAW 264.7 murine macrophages.
Utilizing modiﬁed kanamycin-protection assays,
B. mallei was shown to survive and replicate in RAW
264.7 cells infected at multiplicities of infection (moi)
of  1. In contrast, the organism was efficiently
clearedbythemacrophageswheninfectedatanmoiof
10. Interestingly, studies demonstrated that the mono-
layers only produced high levels of TNF-a, IL-6, IL-10,
GM-CSF,RANTESandIFN-bwheninfectedatanmoiof
10. In addition, nitric oxide assays and inducible nitric
oxide synthase (iNOS) immunoblot analyses revealed
a strong correlation between iNOS activity and clear-
ance of B. mallei from RAW 264.7 cells. Furthermore,
treatment of activated macrophages with the iNOS
inhibitor, aminoguanidine, inhibited clearance of
B. mallei from infected monolayers. Based upon these
results, it appears that moi signiﬁcantly inﬂuence the
outcome of interactions between B. mallei and murine
macrophages and that iNOS activity is critical for the
clearance of B. mallei from activated RAW 264.7 cells.
Introduction
Burkholderiamalleiisanon-motile,facultativeintracellular,
Gram-negative bacillus that causes a debilitating disease
known as glanders. This zoonotic pathogen is an obligate
animal parasite that is primarily responsible for disease in
solipeds and occasionally other mammals, including
humans (Howe and Miller, 1947; Redfearn et al., 1966;
Yabuuchi et al., 1992; Srinivasan et al., 2001). In regions
where glanders remains endemic, chronically infected
horses are the only known reservoir of this bacterial patho-
gen. Human infections, although rare, are thought to be
acquiredviatheinoculationofmucocutaneoustissueswith
aerosols or secretions from diseased animals. The clinical
progression of human glanders is similar to that observed
in solipeds and may manifest as chronic or acute localized
infections, acute pulmonary infections or fulminating sep-
ticemias.Intheabsenceofchemotherapeuticintervention,
glanders is invariably fatal (Wilkinson, 1981; Dance, 1996;
Bartlett, 2005). Because of this, the Centers for Disease
Control and Prevention currently list B. mallei as a cat-
egory B biothreat agent (Rotz et al., 2002).
Studies have demonstrated that B. mallei expresses a
number of important virulence determinants that are
required for survival in various animal models of infection.
Included among these are a capsular polysaccharide, the
Bsa type III secretion system (T3SS), a type VI secretion
system and the VirAG two-component gene regulatory
system (DeShazer et al., 2001; Nierman et al., 2004;
Ulrich and DeShazer, 2004; Schell et al., 2007). Recently,
studies have demonstrated that the T3SS expressed by
this organism is important for survival within J774.2
murine macrophages (Ribot and Ulrich, 2006). Consistent
with these ﬁndings, it has been shown that B. mallei uti-
lizes this T3SS in order to facilitate early vacuolar escape
following internalization by the macrophages (Ribot and
Ulrich, 2006). Interestingly, it also appears that the T3SS
is necessary for intra- and intercellular actin-based motil-
ity, presumably by facilitating the ability of B. mallei to
access intracellular pools of actin (Stevens et al., 2005;
Ribot and Ulrich, 2006; Schell et al., 2007). At present,
however, little else is known about the molecular mecha-
nisms utilized by this organism to persist within phago-
cytic cells or to evade speciﬁc host defence responses.
Macrophages play an integral role in the development
of innate and adaptive immune responses against bacte-
rial pathogens. Following stimulation of macrophages
by pathogen-associated molecular patterns (PAMPs),
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No claim to original US government workspattern-recognition receptor (PRR) signalling culminates
in the induction of a variety of bactericidal responses
(Barton and Medzhitov, 2003; Miggin and O’Neill, 2006).
Two of the most potent mechanisms utilized by activated
macrophages to kill bacteria involve the production of
reactive oxygen species (ROS) and reactive nitrogen
oxide species (RNOS) (Coleman, 2001; Vazquez-Torres
and Fang, 2001; Fang, 2004). Inducible nitric oxide syn-
thase (iNOS) is responsible for generating high levels of
nitric oxide (NO) in activated macrophages. In biological
systems, RNOS are then formed by the rapid oxidation of
NO to reactive species such as nitrogen dioxide and dini-
trogen trioxide (MacMicking et al., 1997; Coleman, 2001;
Fang, 2004). Under conditions favouring the production of
high concentrations of both NO and superoxide anion, the
highly reactive peroxynitrite anion is also generated. In
activated macrophages, RNOS play an important role in
the clearance of intracellular bacteria due to their cyto-
toxic effects (MacMicking et al., 1997; Coleman, 2001).At
low concentrations, RNOS are unstable and rapidly nitro-
sate amines and thiols, whereas at higher concentrations,
they induce lipid peroxidation as well as nitrosate
iron-/sulfur-containing reactive centres, nucleic acids and
tyrosine residues (Coleman, 2001; Fang, 2004).
Many intracellular bacteria have developed mecha-
nisms to avoid killing by phagocytic cells. Some of these
include the ability to prevent phagosomal maturation, pha-
gosomal lysis, phagosomal acidiﬁcation, and inhibition of
the respiratory burst, as well as the production of detoxi-
ﬁers that can counteract the bactericidal effects of ROS
and RNOS (Collins and Kaufmann, 2001; Smith et al.,
2001; Fang, 2004). Recently, studies have demonstrated
that, following uptake by a variety of murine macrophage
cell lines, Burkholderia pseudomallei and B. cepacia were
poor activators of iNOS expression and NO production
respectively (Saini et al., 1999; Utaisincharoen et al.,
2001). Based upon these observations, it has been pro-
posed that these organisms may be capable of interfering
with RNOS responses in order to promote their survival
within phagocytic cells. To date, few studies have exam-
ined the survival characteristics of B. mallei within phago-
cytic cells. In the present study, we utilized a combination
of cellular, immunological and biochemical approaches to
investigate the interactions of this organism with RAW
264.7 murine macrophages. In addition, we assessed
the importance of iNOS activity with regard to these
interactions.
Results
Inﬂuence of multiplicity of infection (moi) on B. mallei
interactions with RAW 264.7 cells
Previous studies have shown that a number of pathogenic
Burkholderia species, including B. pseudomallei and
B. cenocepacia, are able to survive and replicate within
RAW 264.7 murine macrophages (Jones et al., 1997;
Miyagi et al., 1997; Utaisincharoen et al., 2001; Lamothe
et al., 2007). To examine the ability of B. mallei to survive
within this cell line, bacterial uptake and intracellular sur-
vival phenotypes were characterized utilizing modiﬁed
kanamycin-protection assays. To optimize initial assay
conditions, monolayers were infected with B. mallei at moi
ranging from 0.1 to 10. As would be predicted, results
demonstrated that uptake of B. mallei by the mono-
layers increased in a dose-dependent fashion
(3 h; Fig. 1). Curiously, B. mallei was shown to survive
and replicate in RAW 264.7 cells infected at moi of  1,
but not at an moi of 10 (24 h; Fig. 1).
Several studies have shown that B. pseudomallei and
B. cenocepacia have the ability to cause signiﬁcant mor-
phological changes in RAW 264.7 cell monolayers follow-
ing infection (Utaisincharoen et al., 2001; 2004; Lamothe
et al., 2007). To exclude the possibility that our inability to
recover B. mallei from infected RAW 264.7 cells at an moi
of 10 was due to monolayer destruction, ﬁxed cells were
examined using light and confocal microscopy at 24 h post
infection. In comparison with control cells, monolayers
infected with B. mallei at moi ranging from 0.1 to 10
appearedgenerallyhealthyandintact(Fig. 2A–C,E).Inter-
estingly, sporadic multinucleated giant cell (MNGC) forma-
tion and evidence of actin-based motility were observed in
monolayers infected at an moi of 1 but not at an moi of 10
(Fig. 2C–D). In stark contrast, monolayers infected with
B. pseudomallei at an moi of 10 for control purposes,
demonstrated signiﬁcant MNGC formation and monolayer
sloughing (Fig. 2F). Consistent with these observations,
cytotoxicity assays also demonstrated that B. pseudoma-
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Fig. 1. Survival characteristics of B. mallei in RAW 264.7 cells.
Monolayers were infected with B. mallei at moi ranging from 0.1 to
10. Uptake (white bars) and intracellular survival (black bars) were
quantiﬁed at 3 and 24 h post infection respectively. Values
represent the means  SD of three independent experiments.
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more lactate dehydrogenase (LDH) than B. mallei at all
moi tested (Fig. 3). Taken together, these ﬁndings indi-
cated that, in contrast to other closely related Burkholderia
species, RAW 264.7 cells appeared to be capable of killing
B. mallei when infected at a critical moi ( 10).
Burkholderia mallei is a weak activator of
RAW 264.7 cells
Macrophages are known to play a critical role in the clear-
ance of bacterial pathogens from host tissues. Upon acti-
vation, macrophages produce a variety of cytokines and
chemokines that serve to regulate host defence mecha-
nisms involved in these events (Collins and Kaufmann,
2001; Smith et al., 2001). To characterize the activation
status of the B. mallei-infected RAW 264.7 monolayers,
culture supernatants harvested at 6 and 18 h post infec-
tion were assayed for the production of a variety of pro-
and anti-inﬂammatory cytokines and chemokines. At both
6 and 18 h, B. mallei was shown to be a relatively weak
activator of the macrophages in comparison with Escheri-
chia coli controls (Fig. 4A–J). In addition, although mono-
layers infected with B. mallei at moi of 1 and 10 produced
signiﬁcant amounts of TNF-a, only those infected at the
higher moi of 10 were shown to produce high levels of
Fig. 2. Microscopic analysis of RAW 264.7
cells infected with B. mallei and
B. pseudomallei. Monolayers were ﬁxed and
examined at 24 h post infection. Light
micrographs: (A) mock infected, (B) B. mallei
moi 0.1, (C) B. mallei moi 1, (E) B. mallei moi
10, and (F) B. pseudomallei moi 10. Black
scale bars = 1 mm.
D. Confocal micrograph of RAW 264.7 cells
infected with B. mallei at an moi of 1. Bacteria
were stained red with rabbit anti-Burkholderia
thailandensis polyclonal sera and anti-rabbit
IgG Alexa Fluor
® 568, actin was stained green
with Alexa Fluor
® 488 phalloidin, and nuclei
were stained blue with DRAQ5™. White scale
bar = 20 mm. Micrographs are representative
of at least three independent experiments.
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upon these ﬁndings, a strong correlation appeared to exist
between the activation status of the infected macroph-
ages and their ability to clear intracellular B. mallei.
INOS activity correlates with clearance of B. mallei from
activated RAW 264.7 cells
IFN-b is an important modulator of innate host defence
responses. For example, by acting in an autocrine
fashion, IFN-b can augment bactericidal effector mecha-
nisms by enhancing iNOS expression in activated
macrophages (Thomas et al., 2006). Interestingly, studies
have shown that, following infection with B. pseudomallei,
IFN-b is only weakly produced by RAW 264.7 cells
(Utaisincharoen et al., 2004). To examine the ability of
B. mallei to stimulate RAW 264.7 cells to produce this
cytokine, culture supernatants harvested at 6 h post infec-
tion were assayed for IFN-b by ELISA. Consistent with the
results described in Fig. 4, B. mallei was shown to be a
relatively weak activator of IFN-b production in compari-
son with E. coli. Furthermore, monolayers were only
shown to produce signiﬁcant levels of this cytokine when
infected at an moi of 10 (Fig. 5A).
Production of ROS and RNOS is known to be important
for the killing of a variety of pathogens by activated
macrophages. Previous studies have demonstrated that
RNOS are important in the control of infections caused by
B. pseudomallei and B. cepacia (Miyagi et al., 1997;
Saini et al., 1999). Studies have shown, however, that
B. pseudomallei appears to be able to interfere with iNOS
expression in RAW 264.7 cells (Utaisincharoen et al.,
2001; 2004). To assess the ability of B. mallei to stimulate
RAW 264.7 cells to produce NO, culture supernatants
harvested at 24 h post infection were assayed for nitrite
using Griess reagent. Unlike the results observed for the
E. coli controls, high levels of NO were only produced by
monolayers infected with B. mallei at an moi of 10
(Fig. 5B). Consistent with these observations, immunoblot
Fig. 3. Cellular integrity of RAW 264.7 cells infected with B. mallei
and B. pseudomallei. Monolayers were infected with B. mallei
at moi 0.1 (Bm 0.1), moi 1 (Bm 1), moi 10 (Bm 10) and
B. pseudomallei at moi 10 (Bp 10). Per cent cytotoxicity was
determined by assaying for LDH release in culture supernatants at
24 h post infection. Values represent the means  SD of three
independent experiments assayed in duplicate.
Fig. 4. B. mallei is a weak activator of RAW 264.7 cells. Culture supernatants from monolayers infected with B. mallei (open circles) or E. coli
(ﬁlled circles) at moi ranging from 0.1 to 10 were harvested at (A–E) 6 h or (F–J) 18 h post infection and assayed for the production of
(A and F) TNF-a, (B and G) IL-6, (C and H) IL-10, (D and I) GM-CSF, and (E and J) RANTES. Values represent the means  SD of three
independent experiments assayed in duplicate.
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B. mallei-infected monolayers demonstrated a strong cor-
relation between iNOS expression and NO production
(Fig. 5C).
To further examine the importance of iNOS activity with
regards to B. mallei killing, experiments were conducted
in an attempt to correlate bacterial survival with RAW
264.7 cell activation, iNOS expression and NO pro-
duction. Following infection of the monolayers at a critical
moi of 10, bacterial survival was shown to steadily
decrease to zero over a 24 h period (Fig. 6A). By moni-
toring TNF-a and RANTES levels, macrophages were
shown to be highly activated over the course of the assay
(Fig. 6B and C). In addition, NO levels were also shown to
increase in a linear fashion over the 24 h period (Fig. 6D).
Consistent with these results, immunoblot analysis of
iNOS levels correlated with both NO production and
bacterial killing (Fig. 6E). Taken together, these ﬁndings
indicated that when infected at a critical moi, iNOS-
dependent mechanisms appeared to be important in the
clearance of intracellular B. mallei from RAW 264.7 cells.
Inhibition of iNOS activity facilitates survival of B. mallei
in activated RAW 264.7 cells
To conﬁrm that iNOS activity was important for the clear-
ance of intracellular B. mallei from RAW 264.7 cells,
modiﬁed kanamycin-protection assays, using the iNOS
inhibitor aminoguanidine (AG), were performed at an
moi of 10. Results of these assays demonstrated that,
in comparison with controls, treatment with AG
(200 mgm l -1) appeared to have little impact on bacterial
uptake (Fig. 7A). Quantiﬁcation of intracellular bacteria at
24 h post infection also demonstrated that B. mallei was
cleared by activated macrophages in the absence of AG.
However, in the presence of AG, survival was shown to
increase >10 000-fold over control levels (Fig. 7A). To
conﬁrm that AG did not inhibit macrophage activation,
culture supernatants were assayed for pro-inﬂammatory
cytokine and chemokine production. Results of these
analyses demonstrated that, whether incubated in the
presence or absence of AG, infected monolayers pro-
duced signiﬁcantly higher levels of TNF-a and RANTES
than the mock-infected cells (Fig. 7B and C). Consistent
with predicted results, high levels of NO were only pro-
duced by infected monolayers in the absence of AG
(Fig. 7D). Importantly, immunoblot analyses of cell lysates
conﬁrmed that the decreases in NO production were not
due to reduced iNOS expression, but due to the inhibition
of iNOS activity by the AG (Fig. 7E). Based upon these
ﬁndings, iNOS activity appeared to be critical for the clear-
ance of B. mallei by activated RAW 264.7 cells.
Lipopolysaccharide (LPS) stimulates the clearance of
B. mallei from RAW 264.7 cells
Toll-like receptor (TLR) signalling is an important means
by which phagocytic cells are activated by PAMPs
(Carpenter and O’Neill, 2007). Numerous studies have
demonstrated that E. coli LPS is a potent activator of
murine macrophages (Weisz et al., 1994; Zughaier et al.,
2005; Okemoto et al., 2006). In particular, RAW 264.7
cells stimulated with E. coli LPS are known to produce
high levels of NO (Weisz et al., 1994; Zughaier et al.,
2005). To conﬁrm the relationship between activated RAW
264.7 cells, iNOS activity and bacterial clearance, mono-
layers infected with B. mallei at an moi of 1 were incu-
bated with various combinations of AG (200 mgm l -1) and
LPS (100 ng ml-1). Results of these assays demonstrated
that uptake levels did not appear to be inﬂuenced by the
AG and LPS treatments (Fig. 8A). Quantiﬁcation of intra-
cellular survival at 24 h post infection demonstrated that
B. mallei was cleared by RAW 264.7 cells treated with
LPS alone. In contrast, B. mallei was shown to survive in
AG-treated macrophages even in the presence of LPS
(Fig. 8A). In order to correlate intracellular survival with
Fig. 5. Production of IFN-b and NO by B. mallei- and
E. coli-infected RAW 264.7 cells. Culture supernatants from
monolayers infected with B. mallei (white bars) or E. coli (black
bars) at moi of 1 and 10 were harvested (A) 6 h and (B) 24 h post
infection and assayed for the production of IFN-b and NO
respectively. Supernatants from mock-infected monolayers were
included as negative controls. Values represent the means  SD of
three independent experiments assayed in duplicate or triplicate.
C. Cell lysates prepared from E. coli-infected and B. mallei-infected
monolayers harvested 24 h post infection were assayed for the
presence of iNOS by immunoblot analysis. b-actin was included as
a loading control. Results are representative of three independent
experiments.
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infection were assayed for NO production. Consistent with
predicted results, high levels of NO were only produced
by infected monolayers in the absence of AG (Fig. 8B).
Taken together, these ﬁndings indicated that when
infected at a subcritical moi ( 1), RAW 264.7 cells could
be stimulated by LPS to clear B. mallei in an iNOS-
dependent manner.
Fig. 6. Clearance of B. mallei from activated
RAW 264.7 macrophages correlates with
iNOS activity. Monolayers were infected with
B. mallei at an moi of 10.
A. Bacterial loads were determined at 3, 6,
12, 18 and 24 h post infection. Values
represent the means  SD of three
independent experiments. Culture
supernatants harvested at 3, 6, 12, 18 and
24 h from mock-infected (open circles) and
B. mallei-infected (ﬁlled circles) monolayers
were assayed for the production of (B) TNF-a,
(C) RANTES, and (D) NO. Values represent
the means  SD of three independent
experiments assayed in duplicate or triplicate.
E. Cell lysates prepared from
B. mallei-infected monolayers harvested at 3,
6, 12, 18 and 24 h post infection were
assayed for the presence of iNOS by
immunoblot analysis. b-actin was included as
a loading control. Results are representative
of three independent experiments.
Fig. 7. Inhibition of iNOS activity facilitates
survival of B. mallei in activated RAW 264.7
cells. Monolayers infected with B. mallei (Bm)
at an moi of 10 were incubated in the
absence or presence of AG (200 mgm l
-1)a t
1 h post infection.
A. Uptake (white bars) and intracellular
survival (black bars) were determined at 3
and 24 h post infection respectively. Values
represent the means  SD of three
independent experiments. Culture
supernatants harvested at 24 h post infection
from mock-infected and B. mallei-infected
monolayers were assayed for the production
of (B) TNF-a, (C) RANTES and (D) NO.
Values represent the means  SD of three
independent experiments assayed in duplicate
or triplicate.
E. Cell lysates prepared from mock-infected
and B. mallei-infected monolayers harvested
at 24 h post infection were assayed for the
presence of iNOS by immunoblot analysis.
b-actin was included as a loading control.
Results are representative of three
independent experiments.
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The ability of B. mallei to persist within professional
phagocytic cells is thought to be an important means by
which this organism evades speciﬁc host immune
responses. Previous reports have shown that B. mallei is
able to survive and replicate within J774.2 macrophages
and that these phenotypes are dependent upon the
expression of the Bsa T3SS (Ribot and Ulrich, 2006). In
the present study, we characterized the interactions of
B. mallei with RAW 264.7 murine macrophages and dem-
onstrated that moi signiﬁcantly affected the outcome of
these events. Utilizing modiﬁed kanamycin-protection
assays, initial studies demonstrated that B. mallei was
internalized in an moi-dependent fashion. However, it
appeared that the uptake levels for this organism were
signiﬁcantly lower (10- to 100-fold) than those typically
observed in our laboratory for B. pseudomallei as well as
those previously described for B. cenocepacia (P.J. Brett
and F.C. Gherardini, unpublished; Lamothe et al., 2007).
At present, the reason for this phenomenon remains
unclear. Recent ﬁndings in our laboratory, however,
suggest that ﬂagella may play an important role in the
uptake of pathogenic Burkholderia species by RAW 264.7
cells. In particular, B. pseudomallei motility mutants have
been shown to exhibit reduced uptake in comparison
to parental strains (P.J. Brett and F.C. Gherardini,
unpublished). Consistent with these observations, studies
by Inglis et al. (2003) have also demonstrated that the
ﬂagellar apparatus expressed by B. pseudomallei assists
entry into Acanthamoeba astronyxis trophozoites.
Previous studies have demonstrated that several
pathogenic Burkholderia species are able to persist in a
variety of human and murine cell types, and that signiﬁ-
cant cellular abnormalities are often observed upon infec-
tion with these organisms (Jones et al., 1997; Miyagi
et al., 1997; Harley et al., 1998; Saini et al., 1999; Kes-
pichayawattana et al., 2000; Utaisincharoen et al., 2001;
Lamothe et al., 2007). B. pseudomallei and B. mallei, for
instance, have been shown to cause MNGC formation
both in vitro and in vivo (Duval and White, 1907; Harley
et al., 1998; Kespichayawattana et al., 2000). This unique
phenomenon is thought to be due in part to the actin-
based intra- and intercellular motility phenotypes
displayed by these pathogens (Harley et al., 1998; Kes-
pichayawattana et al., 2000; Stevens et al., 2002; Breit-
bach et al., 2003). B. cenocepacia, in addition, is known
to persist within phagocytic vacuoles and cause a variety
of morphological changes in RAW 264.7 cells, including
rounding, ﬁlamentation and the development of highly
dense cytoplasms (Saini et al., 1999; Lamothe et al.,
2007). In the present study, B. mallei was shown to
survive and replicate in RAW 264.7 cells only when
infected at moi of 0.1 and 1, but not at an moi of 10. As
demonstrated by light microscopy and cytotoxicity
assays, these results could not simply be explained by
macrophage destruction because the monolayers
infected at the moi of 10 were seemingly healthy and
intact. Based upon these ﬁndings, it appears that, in com-
parison with other pathogenic Burkholderia species,
B. mallei demonstrates rather unique survival character-
istics in RAW 264.7 cells. Studies are ongoing to deter-
mine whether or not this clearance phenotype is speciﬁc
to RAW 264.7 cells.
In this study, we demonstrated that B. mallei is a rela-
tively weak activator of RAW 264.7 cells in comparison
with E. coli controls. Results indicated that on an moi
basis, 10- to 100-fold more B. mallei than E. coli were
required to stimulate infected monolayers to produce
similar levels of cytokines and chemokines.At present the
reasons for these ﬁndings are unclear. Studies in our
laboratory, however, indicate that this may be an LPS-
related phenomenon. Recently, we demonstrated that
B. mallei expresses complex mixture of tetra- and penta-
acylated lipid A species that are similar in structure to
those expressed by other pathogenic Burkholderia
species (De Soyza et al., 2004; Silipo et al., 2005; Brett
et al., 2007). In addition, we demonstrated that B. mallei
LPS was a potent activator of human TLR4 complexes
and stimulated THP-1 cells, U937 cells as well as human
monocyte-derived macrophages and dendritic cells to
produce high levels of TNF-a, IL-6 and RANTES (Brett
et al., 2007). Interestingly, preliminary studies in our labo-
Fig. 8. E. coli LPS stimulates the clearance of B. mallei from RAW
264.7 cells infected at an moi of 1. Infected monolayers were
incubated with either AG (200 mgm l
-1), LPS (100 ng ml
-1), or AG
(200 mgm l
-1) and LPS (100 ng ml
-1) at 1 h post infection.
A. Uptake (white bars) and intracellular survival (black bars) were
determined at 3 and 24 h post infection respectively. Values
represent the means  SD of three independent experiments.
B. Culture supernatants harvested 24 h post infection from
mock-infected and B. mallei-infected monolayers were assayed for
the production of NO. Values represent the means  SD of three
independent experiments assayed in triplicate.
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LPS, is a less potent activator of RAW 264.7 cells than
E. coli LPS (P.J. Brett and F.C. Gherardini, unpublished;
Utaisincharoen et al., 2000). To what extent LPS inﬂu-
ences the ability of B. mallei to stimulate RAW 264.7 cells
remains to be experimentally deﬁned. In addition, studies
are ongoing to determine why RAW 264.7 cells appear to
be less responsive to B. mallei LPS than human tissue
cell lines and primary phagocytic cells.
Interferons are pro-inﬂammatory cytokines involved in
both innate and acquired immune responses. One of the
most important functions of these cytokines appears to be
the sensitization of macrophages to PAMPs (Takaoka and
Yanai, 2006). Additionally, both type I (IFN-b) and type II
(IFN-g) interferons are known to enhance iNOS expres-
sion by macrophages (Boehm et al., 1997; MacMicking
et al., 1997; Rottenberg et al., 2000). Previous studies
have shown that many pathogenic Burkholderia species
are rapidly killed by IFN-g-activated macrophages (Miyagi
et al., 1997; Utaisincharoen et al., 2001). The molecular
mechanism(s) by which these organisms are cleared,
however, appear to greatly depend upon the lineage of
the macrophage. Reports by Miyagi et al. (1997) have
demonstrated that J774.1 murine macrophage-like cells
can be activated with IFN-g to clear intracellular
B. pseudomallei and that optimal killing by these cells
appeared to rely upon the presence of both ROS and
RNOS. Similarly, studies by Utaisincharoen et al. (2001;
2003; 2004) have shown that B. pseudomallei can be
cleared by IFN-g-activated RAW 264.7 cells and that iNOS
activity is important for bacterial killing. However, recent
studies by Breitbach et al. (2006) have demonstrated that
IFN-g-activated C57BL/6 bone marrow-derived macroph-
ages are capable of killing B. pseudomallei in an iNOS-
independent manner. Based upon these ﬁndings, it
appears likely that pathogenic Burkholderia species may
be cleared from activated macrophages via both RNOS-
dependent and RNOS-independent mechanisms.
IFN-b is a dominant factor in the shaping of innate and
adaptive immune responses. Soon after activation, IFN-b
produced by macrophages mediates target gene expres-
sion via the activation of JAK-STAT signalling pathways
(Theoﬁlopoulos et al., 2005). Importantly, IFN-b has been
shown to be a necessary component of signalling pro-
cesses leading to the induction of iNOS gene expression
in murine macrophages (Jacobs and Ignarro, 2001;
Thomas et al., 2006). In the present study, we demon-
strated that clearance of B. mallei by activated RAW
264.7 cells strongly correlated with both IFN-b production
and iNOS activity. In addition, time-course assays dem-
onstrated that the kinetics of B. mallei killing by activated
RAW 264.7 cells correlated directly with the kinetics of NO
production. These results, in combination with those
obtained from the AG inhibition assays, suggested a criti-
cal role for iNOS activity and RNOS production in clear-
ance of B. mallei from activated RAW 264.7 cells. At
present, whether or not RNOS produced by activated
RAW 264.7 cells function synergistically with other mac-
rophage effector species (i.e. ROS) to clear B. mallei
remains to be deﬁned. It also remains to be determined
why infection of RAW 264.7 cells with B. mallei resulted in
high levels of iNOS expression/activity compared with
other pathogenic Burkholderia species (Saini et al., 1999;
Utaisincharoen et al., 2001; 2004).
Toll-like receptors are a family of PRRs that are impor-
tant in the development of both innate and adaptive
immune responses. All TLRs activate a common signal-
ling pathway that results in the activation of nuclear factor-
kappa B transcription factors, mitogen-activated protein
kinases, p38 and JNK (Barton and Medzhitov, 2003).
TLRs are activated in response to a variety of PAMPs
expressed by bacteria, viruses, fungi and protozoa. Fol-
lowing recognition of PAMPs, a cascade of intracellular
signalling events is activated, which results in the stimu-
lation of pro-inﬂammatory cytokines such as TNF-a and
IL-6 (Miggin and O’Neill, 2006). Additionally, production of
type I interferons may be induced via the stimulation of a
number of TLRs, including TLR4 (Miggin and O’Neill,
2006). Mounting evidence suggests that TLR agonists
have signiﬁcant potential in the treatment of a number
of disease conditions (Pandey and Agrawal, 2006).
Recently, Waag et al. (2006) demonstrated that BALB/c
mice could be protected from an aerosol challenge of
B. mallei using the TLR9 agonist CpG ODN 7909. In the
present study, we have demonstrated that macrophages
infected with B. mallei at a subcritical moi could be stimu-
lated with the prototypic TLR4 agonist, LPS, to clear intra-
cellular bacteria. In addition, it was shown that clearance
of B. mallei from infected RAW 264.7 cells correlated
strongly with iNOS activity, supporting the prediction that
RNOS are important for killing this organism. Studies are
ongoing to more fully characterize the role of TLR signal-
ling in the clearance of B. mallei from RAW 264.7 cells.
In summary, we have demonstrated that iNOS activity is
critical for the clearance of B. mallei from activated RAW
264.7 cells. In addition, we have shown that macrophages
infected with B. mallei at a subcritical moi can be stimu-
lated by LPS to kill the organism in an iNOS-dependent
manner. In order to more fully characterize the importance
of speciﬁc macrophage effector mechanisms against this
organism, however, experiments utilizing primary mac-
rophages derived from a variety of wild-type and trans-
genic mice will need to be conducted. Studies are ongoing
to address this as well as examine the interactions of
B. mallei with human and equine macrophages. Future
studies are also planned to investigate reasons underly-
ing the differential survival phenotypes of B. pseudomallei
and B. mallei within RAW 264.7 cells.
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Bacterial strains, growth conditions and reagents
Escherichia coli HB101 was obtained from the American Type
CultureCollection(ATCC).B. malleiATCC23344(Yabuuchiet al.,
1992) and B. pseudomallei DD503 (Moore et al., 1999) were
kindly provided by Dr Donald Woods (University of Calgary).
E. coli was grown at 37°C on LB-Lennox (LBL; Difco) agar or in
LBL broth. B. mallei and B. pseudomallei were grown at 37°C on
LBLagar or in LBLbroth supplemented with 4% glycerol. Brucella
agar (Difco) supplemented with 4% glycerol (BB4G) was used for
plate counts and sterility analyses. For macrophage assays, bac-
teria were subcultured 1:50 into LB4G broth from overnight cul-
tures and grown at 37°C for 3–4 h. All studies utilizing viable
B. mallei and B. pseudomallei were conducted under biosafety
level 3 containment. Unless stated otherwise, all reagents were
purchased from Sigma. E. coli O55:B5 LPS was extracted four
times with 90% EtOH to remove any contaminating phospholipids
prior to use. LPS stocks were prepared in pyrogen-free water
(Cambrex) and quantiﬁed on a w/v basis.
Cell culture
The murine macrophage cell line RAW 264.7 (ATCC TIB-71) was
obtained from ATCC. The cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Invitrogen) supplemented with
10% (v/v) heat-inactivated fetal bovine serum (FBS; Invitrogen)
and a standard mixture of antibiotics (100 U ml
-1 penicillin,
100 mgm l
-1 streptomycin and 250 mgm l
-1 amphotericin B) at
37°C under an atmosphere of 5% CO2. For macrophage survival
assays, RAW 264.7 cells resuspended in DMEM supplemented
with FBS (DMEM-10) were transferred into 24-well tissue culture
plates at a density of ~1 ¥ 10
6 cells per well and incubated
overnight.
Macrophage survival assays
Bacterial uptake and survival were quantiﬁed utilizing modiﬁed
kanamycin-protection assays. Bacteria grown to early log phase
werepelletedandresuspendedatvariouscelldensitiesinDMEM-
10. The bacterial suspensions were then added in triplicate onto
RAW 264.7 cells at moi ranging from 0.1 to 10. The monolayers
were incubated with the bacteria at 37°C under an atmosphere of
5% CO2 for 1 h and then washed twice with Hanks’ Balanced Salt
Solution (HBSS; Invitrogen) to remove extracellular bacteria.
Infected RAW 264.7 cells were then incubated in fresh DMEM-10
containing 250 mgm l
-1 kanamycin (DMEM-10K) to suppress the
growth of residual extracellular bacteria. At various time points
post infection, monolayers were lysed with 0.25% (v/v) Triton
X-100, and serial dilutions of the lysates were plated onto BB4G
agar and incubated at 37°C for 48 h. Plate counts were then used
to enumerate bacterial loads. Uptake and intracellular survival
were routinely quantiﬁed at 3 and 24 h post infection. For time-
course experiments, uptake and intracellular survival were quan-
tiﬁed at 3, 6, 12, 18 and 24 h respectively.
Light microscopy
Light micrographs of RAW 264.7 monolayers infected with
B. mallei or B. pseudomallei at an moi of 10 were obtained at
24 h post infection. Monolayers were washed twice with
phosphate-buffered saline (PBS) and ﬁxed with 2.5% paraform-
aldehyde for 15 min at room temperature prior to use. Fixed
monolayers were visualized with a Nikon Eclipse TE300
(Nikon Instruments) inverted microscope using a 10¥ objective.
Immunoﬂuorescence staining and confocal microscopy
RAW 264.7 cells were grown overnight on 12 mm glass cover-
slips (Fisher Scientiﬁc) and infected at an moi of 1 using similar
approaches to those described for the macrophage survival
assays. Monolayers were immunostained at room temperature
essentially as previously described (Knodler et al., 2003). Brieﬂy,
at 24 h post infection, monolayers were ﬁxed in 2.5% paraform-
aldehyde for 15 min, followed by extensive washing in PBS. Cells
were then permeabilized in PBS containing 10% normal goat
serum (Invitrogen) and 0.1% (w/v) saponin (SS-PBS) for 20 min.
Cells were incubated with rabbit polyclonal antiserum raised
against formalin-ﬁxed B. thailandensis diluted 1:50 in SS-PBS for
45 min, washed several times in PBS/0.05% (w/v) saponin, and
then incubated with Alexa Fluor
® 568 goat a-rabbit IgG (1:800;
Invitrogen), Alexa Fluor® 488 phalloidin (1:200, Invitrogen) and
DRAQ5™ (1:1000, Alexis Biochemicals) in SS-PBS for a further
45 min. Following extensive washing in PBS, coverslips were
mounted onto glass slides using Mowiol. Laser confocal micro-
scopy was performed with a Zeiss 510 META confocal imaging
system equipped with a Ar, HeNe laser on an inverted Axiovert
200 M microscope using a 63¥ oil objective (Carl Zeiss
MicroImaging). Images of 1024 ¥ 1024 pixels were acquired
using Zeiss 510 META software (Carl Zeiss MicroImaging).
Cytotoxicity assays
Culture supernatants were harvested from infected monolayers
at 24 h and sterilized using 0.45 mm Millex™ syringe driven ﬁlter
units (Millipore Corporation). Aliquots of each were plated onto
BB4G agar and incubated at 37°C for at least 72 h to conﬁrm
sterility. The sterilized supernatants were then assayed for LDH
release using a CytoTox 96
® Non-Radioactive Cytoxicity Assay
kit (Promega). Maximum release was achieved by lysis of
monolayers with Triton X-100 at a ﬁnal concentration of 1%
(v/v). LDH released by uninfected cells was designated as
spontaneous release. Cytotoxicity was calculated as follows:
% cytotoxicity = (test LDH release - spontaneous release)/
(maximal release - spontaneous release).
Cytokine, chemokine and NO assays
Culture supernatants were harvested from infected monolayers
at various time points and sterilized using 0.45 mm Millex™
syringe driven ﬁlter units (Millipore Corporation). Aliquots of each
were plated onto BB4G agar and incubated at 37°C for at least
72 h to conﬁrm sterility. The sterilized supernatants were then
assayed for the production of TNF-a, IL-6, IL-10, GM-CSF and
RANTES using murine SearchLight Custom Multiplex Arrays
(Pierce). IFN-b levels were also determined using a Mouse IFN-
B e t aE L I S Ak i t( R&DS ystems). NO production was estimated
from nitrite levels using a Nitric Oxide Assay Kit (Pierce).
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Infected monolayers were washed three times with HBSS, and
cells were lysed with 150 ml of ice-cold 1¥ RIPA Buffer (Pierce)
supplemented with 1¥ HALT™ Protease Inhibitor Cocktail
(Pierce). The lysates were then mixed with an equal volume of 2¥
Tris-glycine SDS sample buffer (Invitrogen) and heated to 100°C
for 10 min. Aliquots of each were plated onto BB4G agar and
incubated at 37°C for at least 72 h to conﬁrm sterility. Sterilized
lysates were electrophoresed on 10% Tris-glycine gels
(Invitrogen), and proteins were electrophoretically transferred to
nitrocellulose membranes (0.45 mm pore size; Invitrogen). Immu-
noblot analyses were performed at room temperature. Mem-
branes were blocked with Starting Block™ Blocking Buffer
(Pierce) for 15 min and then incubated for 1 h with a 1:2000
dilution of an anti-iNOS mAb (clone NOS-IN) in TBS-T [20 mM
Tris-HCl (pH 7.5), 500 mM NaCl and 0.05% Tween 20]. Mem-
branes were then washed three times with TBS-T and incubated
for 1 h with a 1:5000 dilution of an anti-mouse IgG peroxidase
conjugate in TBS-T. Membranes were washed three more times
with TBS-T, following which the blots were visualized using
ECL™ Plus Western Blotting Detection Reagents (GE
Healthcare). To conﬁrm equal loading of the cell lysates, mem-
branes were stripped with Restore™ Western Blot Stripping
Buffer (Pierce) and re-probed using a 1:4000 dilution of an
anti-b-actin mAb (clone AC-15) and a 1:10000 dilution of the
anti-mouse IgG peroxidase conjugate.
INOS inhibition and LPS stimulation assays
iNOS inhibition and LPS stimulation assays were performed
using similar approaches to those described for the macrophage
survival assays. For iNOS inhibition assays, RAW 264.7 cells
were infected with B. mallei at an moi of 10. The monolayers
were incubated with the bacteria for 1 h and then washed twice
with HBSS. Infected monolayers were then incubated for a
further 2 or 23 h in either DMEM-10K or DMEM-10K containing
200 mgm l
-1 AG. For the LPS stimulation assays, RAW 264.7
cells were infected with B. mallei at an moi of 1. The monolayers
were incubated with the bacteria for 1 h and then washed twice
with HBSS. Infected monolayers were then incubated for a
further 2 or 23 h in DMEM-10K containing 200 mgm l
-1 AG,
DMEM-10K containing 100 ng ml
-1 LPS, or DMEM-10K contain-
ing 200 mgm l -1 AG and 100 ng ml-1 LPS.
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